# PHASE-2A — Data-Only Health Onboarding & Review-Scaling Gate Closure

**Status:** CERTIFIED  
**Date:** 2026-08-15

## Certification decision

Phase-2A is certified against the written exit criteria in `PHASE_2A_DATA_ONLY_HEALTH_ONBOARDING_AND_REVIEW_SCALING_GATE.md`.

The certification is deliberately narrow: Phase-2A proves a credible path to sub-linear review scaling under governed Health onboarding. It does **not** claim that sub-linear scaling has been empirically proven across many products, insurers, document families, or extraction primitives.

## Exit-criterion evidence

### 1. Onboarding workflow mapped

The Phase-2A onboarding path has been exercised across a three-insurer batch using governed registration, classification, product identity, identity resolution, currentness evidence, review-routing applicability, and read-only batch audit artifacts.

### 2. MO-029 review tiers operationalized

MO-029 generic review-risk routing is operational and fail-closed. Reviewer-ready groups are classified by transparent risk flags into critical/high/medium/low routing tiers. Routing does not adjudicate evidence or publish facts.

### 3. Diverse Health batch across multiple insurers

The batch covers:

- Star Health — Star Comprehensive
- Bajaj General Insurance — My Health Care Plan
- Aditya Birla Health — Activ One

The batch audit reports all three complete for the declared audited artifact set.

### 4. Normal-product production-code changes = 0

The batch audit reports zero product-specific production-code changes for the normal onboarding path.

### 5. Product-identity-bearing production-code changes = 0

The standing Phase-2 acceptance criterion is preserved. Product identities and source/version/currentness artifacts remain specification/data driven.

### 6. Material residue explicit

Unresolved conditions remain explicit and fail closed. The remaining Star high-risk groups were not downgraded merely to improve throughput metrics. They represent residual structural ambiguity including dense table row/column binding, unresolved monetary role, or missing governing section context.

### 7. Review effort measured with a credible path to sub-linear scaling

A real reviewer workload was generated from the governed Star Comprehensive policy wording:

- extracted currency candidates: 12
- reviewer-ready groups: 12
- grouping compression: 0%
- initial routing: 12 high, 0 medium, 0 low, 0 critical

The initial result showed a systemic upstream bottleneck: all 12 groups carried `benefit_scope_unresolved`.

Using only reusable, deterministic, review-only scope cues demonstrated by the bounded evidence, the generic currency review layer was improved without changing MO-029 thresholds or adding Star-specific production logic.

The same 12 real candidates were then reprocessed:

- high: 6
- medium: 6
- low: 0
- critical: 0

Senior-review demand therefore fell from 12/12 to 6/12: a measured **50% reduction**.

This is sufficient for the gate's wording of a **credible path** to sub-linear review scaling because the reduction was achieved by reusable upstream context resolution while preserving fail-closed routing. It is not evidence of cross-product asymptotic scaling, and no such claim is made.

### 8. Relevant subsystem regressions = 0

Local Windows validation reported on 2026-08-15:

- focused Phase-2A closing regression set: 32 passed
- affected Star lineage/line-ending integrity set after exact committed-blob restoration: 33 passed
- `tests/health`: 114 passed
- `tests/factory_core`: 127 passed

A local CRLF checkout incident temporarily caused five `factory_core` failures by changing the raw bytes of a hash-bearing Star source bundle. The committed LF artifact and binding hash were verified as consistent. Restoring the exact committed blob bytes resolved the issue without changing production code or lineage hashes.

## Batch audit state at certification

The Phase-2A batch audit reported:

- products: 3
- products with missing data: 0
- missing/undeclared artifacts: 0
- review routing records: 12
- review routing N/A because no reviewer-ready input yet: 2
- risk tiers: critical=0, high=6, medium=6, low=0
- product-specific production-code changes: 0

Star is `required_when_review_input_exists` because real reviewer-ready input exists. Bajaj My Health Care and Activ One remain `not_applicable_no_review_input` until reviewer-ready inputs actually exist; no synthetic workload was created merely to make the audit appear complete.

## Certification guardrails retained

1. Normal new Health onboarding must continue to require zero product-identity-bearing production code.
2. MO-029 thresholds remain unchanged unless independent governance evidence justifies a policy change.
3. Reviewer workload must not be fabricated to improve metrics.
4. Table/column, monetary-role, section-context, and other unresolved semantics remain fail closed.
5. Scope hints remain review-only and distinct from applicability, entitlement, fact acceptance, and publication.
6. Historical product-specific implementations remain compatibility/audit fixtures rather than the Phase-2 scaling template.
7. Database, frontend, Motor, Life, recommendation productization, and unrelated expansion remain outside this gate.

## Explicit non-claims

This certification does **not** claim:

- proof of sub-linear review scaling across multiple real reviewer workloads;
- automated human adjudication;
- elimination of senior review;
- complete table-structure extraction;
- complete Health product coverage;
- publication of the reviewed Star currency candidates as canonical facts;
- readiness for frontend, Motor, Life, or public launch.

## Closure

**PHASE-2A — Data-Only Health Onboarding & Review-Scaling Gate: CERTIFIED.**

The architecture has demonstrated that normal Health expansion can remain governed-data driven, preserve fail-closed review, and reduce expensive review effort through reusable generic context improvements rather than product-specific code or weaker governance.
